A Phase Ib Trial of Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell Carcinoma
|Effective start/end date||5/1/18 → 5/31/22|
- CLEVELAND CLINIC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.